Neuroptix Corporation CEO Paul Hartung To Speak On Non-Invasive Early Detection Of Alzheimer’s At Photon Forum

ACTON, Mass.--(BUSINESS WIRE)--April 10, 2006--Neuroptix Corporation, a Massachusetts-based Alzheimer's and prion disease diagnostics company, today announced that CEO Paul Hartung will be speaking at Photon Forum 2006 in Cambridge, Massachusetts on April 25, to discuss Neuroptix's diagnostic technologies.
MORE ON THIS TOPIC